The Pharmaceutical Regulatory Process

This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Berry, Ira R.
Otros Autores: Martin, Robert P.
Formato: Libro
Lenguaje:inglés
Publicado: New York Informa Healthcare USA Inc. 2021
Edición:2nd ed.
Colección:Drugs and The Pharmaceutical Sciences Series Vol. 185
Materias:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nam a22000007a 4500
008 211012b ||||| |||| 00| 0 eng d
020 |a 9780367202842 
082 |a 344.7304233  |b THE 
100 |a Berry, Ira R.  |9 8386 
245 |a The Pharmaceutical Regulatory Process 
250 |a 2nd ed.  
260 |a New York   |b Informa Healthcare USA Inc.   |c 2021 
300 |a x, 469 p.  
490 |a Drugs and The Pharmaceutical Sciences Series  |v Vol. 185 
520 |a This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval. 
650 |a Pharmacy - Law and Legislation - United States   |9 9252 
650 |a Drugs - Law and Legislation 
700 |a Berry, Ira R.  |9 8386 
700 |a Martin, Robert P.  |9 9253 
952 |0 0  |1 0  |2 ddc  |4 0  |6 344_730423300000000_THE  |7 0  |9 13594  |a 50008178  |b 50008178  |d 2022-06-11  |e PBS  |g 2996.25  |l 0  |o 344.7304233 THE  |p JP001777  |r 2022-06-11 00:00:00  |v 3995.00  |w 2022-06-11  |y RB 
999 |c 7784  |d 7784